Skip to main content
. Author manuscript; available in PMC: 2013 Jan 26.
Published in final edited form as: Bone Marrow Transplant. 2010 Jun 14;46(3):368–371. doi: 10.1038/bmt.2010.119

Table 2.

Multivariate Analysis of Factors Contributing to the Risk of Relapse

Patient Factors RR of relapse (95% C.I.) p-value
PCT
   No*
   Yes
1.00
0		 <.01
Chronic GVHD
   No*
   Yes
1.00
0.15 (0.04–0.59)		 .01
Acute GVHD (grades IIIV)
   No*
   Yes
1.00
0.53 (0.32–0.88)		 .01
*

Reference Group

The above model is the result of multiple regression analysis on relapse after testing the following independent variables: PCT, donor source, HLA match, underlying disease, cGVHD and aGVHD.

RR = relative risk, PCT = pulmonary cytolytic thrombi, BM = bone marrow, UCB = umbilical cord blood, HLA = human leukocyte antigen, ALL = acute lymphoblastic leukemia, AML = acute myelogenous leukemia, CML = chronic myelogenous leukemia, GVHD = graft versus host disease.